Sanmina
SANM
219.41
-8.66
-3.80%
Sanmina
US · SANM
#1300 by market cap
Listed 1970
219.41
-8.66
-3.80%
Live - 5344 symbols - heartbeat 357s ago
· 2026-10-08 04:34
Pre-market
214.95
-2.03%
After-hours
219.41
0.00%
Overnight
219.41
0.00%
- Market cap
- 11.76B
- P/E (TTM)i
- 39.25
- P/Bi
- 4.26
- EPSi
- 4.46
- Div yieldi
- 0.00%
- 52W posi
- 59%
Reader sentiment
Are you bullish or bearish on SANM?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.57, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +7.40% YoY
Margins
- Gross margin
- 8.81%
- Operating margin
- 4.86%
- Net margin
- 3.03%
Key ratios & quality
- Enterprise valuei
- 11.13B
- PEG ratioi
- 51.77
- Altman Z-Scorei
- 3.57
PEG uses trailing P/E against the 3-year net income growth rate (0.76%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 8.23B | 6.95B | 6.74B | 7.92B | 8.94B | -- | 7.57B | 8.13B |
| Gross profit | 591.94M | 517.16M | 526.44M | 622.21M | 743.21M | -- | 640.43M | 716.36M |
| Selling & admin expenses | 260.03M | 240.93M | 234.54M | 244.57M | 255.07M | -- | 266.19M | 290.22M |
| Research & development | 27.55M | 22.56M | 20.91M | 21.34M | 26.43M | -- | 28.51M | 31.09M |
| Operating profit | 304.35M | 253.67M | 270.99M | 356.29M | 461.71M | -- | 345.72M | 395.05M |
| Pretax profit | 245.62M | 192.22M | 281.64M | 302.32M | 412.81M | -- | 317.54M | 339.43M |
| Tax | 104.10M | 59.05M | 32.10M | 61.94M | 85.29M | -- | 79.78M | 73.17M |
| Net profit | 141.52M | 133.17M | 249.55M | 240.38M | 327.51M | -- | 237.75M | 266.26M |
| Basic EPS | 2 | 2 | 4 | 4 | 5 | -- | 4 | 5 |
| Diluted EPS | 1.97 | 1.88 | 3.72 | 3.81 | 5.18 | -- | 3.91 | 4.46 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.98B | 2.04B | 2.10B | 3.19B | 4.01B | 3.46B |
| Gross profit | 176.24M | 181.05M | 191.16M | 242.36M | 353.79M | 363.31M |
| Selling & admin expenses | 76.31M | 69.54M | 73.52M | 114.89M | 113.55M | 109.33M |
| Research & development | 7.32M | 8.08M | 8.67M | 8.66M | 7.99M | 8.27M |
| Operating profit | 92.61M | 103.43M | 108.97M | 117.63M | 230.39M | 243.88M |
| Pretax profit | 88.41M | 91.41M | 73.34M | 61.58M | 131.14M | 191.75M |
| Tax | 17.89M | 18.52M | 21.36M | 9.83M | 33.32M | 66.44M |
| Net profit | 70.52M | 72.89M | 51.97M | 51.76M | 97.82M | 125.31M |
| Basic EPS | 1 | 1 | 1 | 1 | 2 | 2 |
| Diluted EPS | 1.16 | 1.26 | 0.88 | 0.89 | 1.70 | 2.12 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 2.92B | 2.82B | 3.27B | 3.89B | 3.88B | 3.87B | -- | 4.87B |
| Cash & ST investments | 454.74M | 480.53M | 650.03M | 529.86M | 667.57M | 625.86M | -- | 926.27M |
| Inventory | 900.56M | 861.28M | 1.04B | 1.68B | 1.48B | 1.44B | -- | 1.99B |
| Total assets | 3.91B | 3.77B | 4.20B | 4.84B | 4.87B | 4.82B | -- | 5.86B |
| Total current liabilities | 1.68B | 1.52B | 1.79B | 2.47B | 2.03B | 1.94B | -- | 2.82B |
| Short-term debt | 38.35M | 18.75M | 18.75M | 17.50M | 25.95M | 17.50M | -- | 17.50M |
| Long-term debt | 346.97M | 329.25M | 311.57M | 329.24M | 312.33M | 299.82M | -- | 282.97M |
| Total liabilities | 2,262,940,000.00 | 2,142,740,000.00 | 2,350,962,000.00 | 3,015,995,000.00 | 2,555,343,000.00 | 2,461,337,000.00 | -- | 3,319,010,000.00 |
| Total equity | 1.64B | 1.63B | 1.85B | 1.82B | 2.32B | 2.36B | -- | 2.54B |
| Retained earnings | -3.86B | -3.72B | -3.48B | -3.24B | -2.93B | -2.71B | -- | -2.46B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 4.07B | 4.30B | 4.87B | 7.85B | 7.61B | 7.83B |
| Cash & ST investments | 647.14M | 797.88M | 926.27M | 1.42B | 1.58B | 1.84B |
| Inventory | 1.55B | 1.59B | 1.99B | 3.05B | 3.03B | 3.15B |
| Total assets | 4.97B | 5.22B | 5.86B | 9.80B | 9.67B | 9.74B |
| Total current liabilities | 2.07B | 2.25B | 2.82B | 4.62B | 4.44B | 4.40B |
| Short-term debt | 17.50M | 17.50M | 17.50M | 172.00M | 172.00M | 215.00M |
| Long-term debt | 291.39M | 287.18M | 282.97M | 2.00B | 2.00B | 1.96B |
| Total liabilities | 2,571,062,000.00 | 2,746,900,000.00 | 3,319,010,000.00 | 7,139,731,000.00 | 7,057,280,000.00 | 6,980,109,000.00 |
| Total equity | 2.40B | 2.47B | 2.54B | 2.66B | 2.61B | 2.76B |
| Retained earnings | -2.58B | -2.51B | -2.46B | -2.41B | -2.32B | -2.20B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 382.97M | 300.56M | 338.34M | 330.85M | 235.17M | 340.22M | -- | 620.66M |
| Depreciation & amortization | 116.95M | 114.22M | 109.66M | 108.78M | 118.24M | 122.42M | -- | 119.47M |
| Free cash flow | 248.29M | 234.57M | 265.05M | 192.22M | 43.80M | 228.99M | -- | 473.30M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 925.00K | -171.23M | -61.07M | -328.72M | -81.37M | -222.30M | -- | -113.80M |
| Ending cash balance | 454.74M | 480.53M | 650.03M | 529.86M | 667.57M | 625.86M | -- | 966.22M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 156.86M | 200.78M | 199.08M | 178.73M | 398.76M | 124.49M |
| Depreciation & amortization | 28.21M | 29.76M | 29.65M | 39.53M | 47.09M | 48.20M |
| Free cash flow | 126.15M | 163.69M | 136.61M | 91.89M | 342.04M | 23.60M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -84.34M | -13.49M | 147.00K | -79.79M | -159.45M | 0 |
| Ending cash balance | 686.72M | 837.72M | 966.22M | 1.47B | 1.63B | 1.89B |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 9.08 | 8.54 | 15.33 | 13.70 | 15.38 | 10.20 | -- | 10.81 |
| ROA %i | 3.54 | 3.64 | 6.74 | 5.65 | 6.37 | 4.59 | -- | 4.60 |
| ROIC %i | 7.94 | 7.90 | 13.63 | 12.35 | 13.91 | 9.36 | -- | 9.65 |
| 5-year avg ROE %i | 10.15 | 6.33 | 6.79 | 7.70 | 12.04 | 12.26 | -- | 12.79 |
| EBIT margin %i | 3.36 | 3.30 | 4.83 | 4.35 | 5.03 | 4.58 | -- | 4.42 |
| FCF / sales %i | 3.02 | 3.37 | 3.92 | 2.44 | 0.49 | 3.03 | -- | 5.82 |
| Current ratioi | 1.74 | 1.85 | 1.83 | 1.57 | 1.91 | 1.99 | -- | 1.72 |
| Quick ratioi | 1.18 | 1.26 | 1.22 | 0.87 | 1.15 | 1.21 | -- | 0.98 |
| Debt / assetsi | 9.87 | 9.22 | 7.86 | 7.17 | 6.94 | 6.58 | -- | 5.13 |
| LT debt / equityi | 21.12 | 20.20 | 16.82 | 18.09 | 14.40 | 13.65 | -- | 12.02 |
| Interest coveragei | 8.98 | 7.95 | 16.70 | 15.27 | 12.38 | 11.88 | -- | 17.84 |
| Revenue CAGR (3Y) %i | 8.31 | 0.39 | -1.77 | -1.29 | 8.73 | 3.95 | -- | 0.87 |
| Net income CAGR (3Y) %i | -9.01 | -1.38 | -- | 19.32 | 32.53 | -3.75 | -- | 0.76 |
| FCF CAGR (3Y) %i | -2.72 | 19.02 | 91.84 | -8.18 | -42.84 | -4.76 | -- | 35.04 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 11.03 | 11.58 | 10.81 | 9.75 | 11.19 | 12.70 |
| ROA %i | 5.02 | 5.24 | 4.60 | 3.15 | 3.55 | 4.12 |
| ROIC %i | 9.96 | 10.35 | 9.65 | 6.81 | 8.20 | 9.65 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 4.57 | 4.63 | 4.42 | 3.81 | 3.74 | 4.33 |
| FCF / sales %i | 3.41 | 4.54 | 5.82 | 5.57 | 6.47 | 4.66 |
| Current ratioi | 1.96 | 1.91 | 1.72 | 1.70 | 1.71 | 1.78 |
| Quick ratioi | 1.16 | 1.15 | 0.98 | 0.97 | 0.96 | 0.99 |
| Debt / assetsi | 6.22 | 5.83 | 5.13 | 22.15 | 22.46 | 22.30 |
| LT debt / equityi | 13.13 | 12.52 | 12.02 | 80.80 | 82.64 | 76.47 |
| Interest coveragei | 15.92 | 18.64 | 17.84 | 8.89 | 6.33 | 5.84 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Reportable segment - Integrated Manufacturing Solutions (IMS) is the largest reported line at 85.36% of revenue, across 3 reported segments.
- The next-largest line, Other segments - Components, Products and Services (CPS), is a distant second at 15.76% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Reportable segment - Integrated Manufacturing Solutions (IMS)85.36%
Other segments - Components, Products and Services (CPS)15.76%
Quote time 2026-10-08 04:34:59 · For reference only, not investment advice and not tailored to your situation.